Indeed, besides the presence of inhibitory anti-ADAMTS13 antibodies in patients’ plasma, Thomas et al. recently suggested that ADAMTS13 clearance might be a major pathological mechanism in acquired TTP [36]. Here, ADAMTS13 is linked to thrombotic thrombocytopenic purpura.